David Roblin, COO and Director of Scientific Translation, to join Summit

David Roblin, Chief Operating Officer and Director of Scientific Translation for the Francis Crick Institute since 2014, is to become Chief Operating Officer and President of Research & Development for Summit Therapeutics, a biopharmaceutical company that targets Duchenne muscular dystrophy (DMD) and C. difficile infection.
18 January 2017

Supporting actors take lead role as our brains age

Brain cells that support neurons change most as we get older, suggesting a new focus for dementia research
10 January 2017

Researchers reveal how cancer cells cope with genetic chaos

Scientists have uncovered how tumours are able to grow despite significant damage to the structure and number of their chromosomes, according to two new studies.
09 January 2017

Knighthood for Jim Smith

Professor Jim Smith, Group Leader and until recently Research Director at the Francis Crick Institute, has been knighted in the Queen's New Year Honours for services to medical research and science education.
30 December 2016

Discovery of gene effects on brain brings scientists closer to understanding rare developmental disorder

Researchers have revealed the effects on the developing brain of a gene that causes Cornelia de Lange Syndrome and have identified two possible candidates for screening for genetic mutations.
29 December 2016